KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Qorvo (QRVO) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Qorvo (QRVO) over the last 13 years, with Q4 2025 value amounting to $1.3 billion.

  • Qorvo's Cash & Equivalents rose 7136.15% to $1.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.3 billion, marking a year-over-year increase of 7136.15%. This contributed to the annual value of $1.0 billion for FY2025, which is 78.52% down from last year.
  • Qorvo's Cash & Equivalents amounted to $1.3 billion in Q4 2025, which was up 7136.15% from $1.1 billion recorded in Q3 2025.
  • In the past 5 years, Qorvo's Cash & Equivalents registered a high of $1.4 billion during Q2 2021, and its lowest value of $706.8 million during Q3 2023.
  • In the last 5 years, Qorvo's Cash & Equivalents had a median value of $1.0 billion in 2024 and averaged $1.0 billion.
  • Over the last 5 years, Qorvo's Cash & Equivalents had its largest YoY gain of 9552.44% in 2021, and its largest YoY loss of 4234.88% in 2021.
  • Qorvo's Cash & Equivalents (Quarter) stood at $1.2 billion in 2021, then dropped by 20.33% to $918.8 million in 2022, then increased by 16.68% to $1.1 billion in 2023, then decreased by 28.22% to $769.4 million in 2024, then surged by 71.36% to $1.3 billion in 2025.
  • Its Cash & Equivalents stands at $1.3 billion for Q4 2025, versus $1.1 billion for Q3 2025 and $1.2 billion for Q2 2025.